pubmed-article:15009716 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1078317 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1513095 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1179435 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1705248 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1947940 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1542147 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1548799 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1524073 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C0449432 | lld:lifeskim |
pubmed-article:15009716 | lifeskim:mentions | umls-concept:C1365461 | lld:lifeskim |
pubmed-article:15009716 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15009716 | pubmed:dateCreated | 2004-3-10 | lld:pubmed |
pubmed-article:15009716 | pubmed:abstractText | The search for innovative therapeutic approaches based on the use of new substances is gaining more interest in clinical oncology. In this in vitro study the potential anti-tumoral activity of tea tree oil, distilled from Melaleuca alternifolia, was analyzed against human melanoma M14 WT cells and their drug-resistant counterparts, M14 adriamicin-resistant cells. Both sensitive and resistant cells were grown in the presence of tea tree oil at concentrations ranging from 0.005 to 0.03%. Both the complex oil (tea tree oil) and its main active component terpinen-4-ol were able to induce caspase-dependent apoptosis of melanoma cells and this effect was more evident in the resistant variant cell population. Freeze-fracturing and scanning electron microscopy analyses suggested that the effect of the crude oil and of the terpinen-4-ol was mediated by their interaction with plasma membrane and subsequent reorganization of membrane lipids. In conclusion, tea tree oil and terpinen-4-ol are able to impair the growth of human M14 melanoma cells and appear to be more effective on their resistant variants, which express high levels of P-glycoprotein in the plasma membrane, overcoming resistance to caspase-dependent apoptosis exerted by P-glycoprotein-positive tumor cells. | lld:pubmed |
pubmed-article:15009716 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15009716 | pubmed:language | eng | lld:pubmed |
pubmed-article:15009716 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15009716 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15009716 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15009716 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15009716 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15009716 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15009716 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15009716 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15009716 | pubmed:month | Feb | lld:pubmed |
pubmed-article:15009716 | pubmed:issn | 0022-202X | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:MolinariAgnes... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:CalcabriniAnn... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:StringaroAnna... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:AranciaGiusep... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:SalvatoreGius... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:MarraManuelaM | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:MondelloFranc... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:MeschiniStefa... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:ToccacieliLau... | lld:pubmed |
pubmed-article:15009716 | pubmed:author | pubmed-author:ColoneMarisaM | lld:pubmed |
pubmed-article:15009716 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15009716 | pubmed:volume | 122 | lld:pubmed |
pubmed-article:15009716 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15009716 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15009716 | pubmed:pagination | 349-60 | lld:pubmed |
pubmed-article:15009716 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:meshHeading | pubmed-meshheading:15009716... | lld:pubmed |
pubmed-article:15009716 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15009716 | pubmed:articleTitle | Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. | lld:pubmed |
pubmed-article:15009716 | pubmed:affiliation | Laboratorio di Ultrastrutture, Istituto Superiore di Sanità, Rome, Italy. | lld:pubmed |
pubmed-article:15009716 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15009716 | pubmed:publicationType | In Vitro | lld:pubmed |
pubmed-article:15009716 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15009716 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15009716 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15009716 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15009716 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15009716 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15009716 | lld:pubmed |